KRAS and colorectal cancer: Thus, if the reovirus treatment influenced those ncRNAs that have been shown to aid in combating colorectal cancer with a positive fold change while downregulating ncRNAs that have been shown to promote tumor growth and metastasis, these results can be seen as support for possible efficacy of reovirus treatment of KRAS-mutated colorectal cancer.